Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer

Rutgers, The State University of New Jersey · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
weight-loss
hormone receptor-positive breast cancer, her2-negative breast cancer, weight loss, body weight reduction, feasibility of weight loss intervention, invasive disease-free survival (idfs), body mass index (bmi), body fat distribution, metabolic markers, circulating tumor dna (ctdna), tirzepatide, gip and glp-1 dual agonist
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 1007125
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.